Investigation of biofilm production and antibiotic susceptibility in Escherichia coli isolated from urinary tract infections

Authors

  • Sumayya Sabah Hussien Department of Medical Laboratory Techniques, College of Health and Medical Techniques, Northern Technical University, Kirkuk 36001, Iraq
  • Mohammed Yawoz Noraldeen Department of Medical Laboratory Techniques, College of Health and Medical Techniques, Northern Technical University, Kirkuk 36001, Iraq https://orcid.org/0000-0001-8718-4364
  • Abdullah Adil Raoof Department of Medicine, Kirkuk Medical College, University of Kirkuk, 36001 Kirkuk, Iraq https://orcid.org/0000-0001-5294-9830

DOI:

https://doi.org/10.56286/44mks696

Keywords:

E. coli, UTI, Biofilm, Antibiotic, Susceptibility

Abstract

Urinary tract infections (UTIs) are among the most common bacterial infections affecting individuals of all age groups and represent a significant public health concern worldwide. They are responsible for a substantial number of hospital admissions and outpatient visits and are frequently associated with recurrent infections, prolonged treatment, and the emergence of multidrug-resistant bacterial pathogens. The increasing prevalence of antimicrobial resistance among uropathogens has complicated the empirical management of UTIs, highlighting the need for continuous surveillance of bacterial isolates and their antimicrobial susceptibility patterns. Therefore, the present study aimed to identify the most common bacterial pathogens causing urinary tract infections and to evaluate the antibiotic sensitivity and resistance profiles of the isolated bacteria. A total of 160 clinical urine samples were collected from patients with suspected UTIs who attended Kirkuk Hospital, Kirkuk City, Iraq, between October 2023 and February 2024. Samples were obtained from hospitalized and outpatient individuals following examination by specialist physicians and referral to the microbiology laboratory. Standard microbiological procedures were used for bacterial isolation and identification, followed by antimicrobial susceptibility testing against a panel of commonly prescribed antibiotics. The findings revealed that Escherichia coli was the predominant bacterial isolate associated with urinary tract infections. The isolate exhibited complete resistance (100%) to ampicillin, indicating that this antibiotic is no longer effective for empirical treatment of E. coli-associated UTIs in the studied population. Low susceptibility rates were observed for vancomycin (23.1%) and clindamycin (23.1%), as well as cefotaxime (12.3%), cefixime (21.5%), nalidixic acid (20.0%), ciprofloxacin (26.2%), levofloxacin (24.6%), trimethoprim (24.6%), and ceftazidime (29.2%). In contrast, higher susceptibility was recorded for gentamicin (75.4%), amikacin (50.8%), azithromycin (89.2%), imipenem (90.8%), while tobramycin demonstrated the highest effectiveness, with 100% sensitivity against the isolated E. coli strains. The study highlights the alarming increase in antimicrobial resistance among uropathogenic E. coli isolates and emphasizes the importance of routine antimicrobial susceptibility testing before initiating antibiotic therapy. The findings also support the use of imipenem, tobramycin, gentamicin, and azithromycin as more effective therapeutic options in the study area while discouraging the empirical use of ampicillin because of its complete resistance. Continuous monitoring of resistance patterns and the implementation of antibiotic stewardship programs are essential to optimize treatment outcomes, reduce the spread of resistant strains, and improve the management of urinary tract infections.

Downloads

Download data is not yet available.

References

Amin A, Noureen R, Iftikhar A, Hussain A, Alonazi WB, Raza HMZ, Ferheen I, Ibrahim M. Uropathogenic bacteria and deductive genomics towards antimicrobial resistance, virulence, and potential drug targets. Int Microbiol. 2024 Feb;27(1):325-335.

Tabassum N., Akter A., and Acharjee M. (2020). Prevalence of Urinary Tract Infection among the Patients Admitted in the Brahmanbaria Medical College Hospital in Bangladesh,” Merit Res. J. Med. Med. Sci., 8(5) 111–119.

Huang L., Huang C., Yan Y., Sun L., and Li H. (2022). Urinary Tract Infection Etiological Profiles and Antibiotic Resistance Patterns Varied Among Different Age Categories: A Retrospective Study From a Tertiary General Hospital During a 12-Year Period,” Front. Microbiol., 12(1) 1-7.

Nobel F. A. (2021). Prevalence of multidrug resistance patterns of Escherichia coli from suspected urinary tract infection in Mymensingh City, bangladesh,” J. Adv. Biotechnol. Exp. Ther., 4(3) 256–264.

Klein R. D. and Hultgren S. J. (2020). Urinary tract infections: microbial pathogenesis, host–pathogen interactions and new treatment strategies,” Nat. Rev. Microbiol., 18(4) 211–226.

Lila A. S. A. (2023). Biofilm Lifestyle in Recurrent Urinary Tract Infections,” Life, 13(1) 1-8.

Radera S, Agarwal J., Srivastava S., Gupta P., Pandey A. (2023). Association of Virulence Markers 11 With Resistance to Oral Antibiotics in Escherichia coli Isolates Causing Uncomplicated CommunityAcquired Cystitis,” Cureus, 15(5) 1–11.

Mostafa M. T., Mustafa K. S., and Kumar B. (2021). Bacterial Causes and their Antimicrobial Susceptibility Testing among Urinary Tract Infection Patients in Tobruk Area, Libya,” AlMukhtar J. Sci., 36(4): 253–262.

Mlugu E. M., Mohamedi J. A., Sangeda R. Z., and Mwambete K. D. (2023). Prevalence of urinary tract infection and antimicrobial resistance patterns of uropathogens with biofilm forming capacity among outpatients in morogoro, Tanzania: a crosssectional study,” BMC Infect. Dis., 23(1) 1–10.

Allami M., Bahreini M., and Sharifmoghadam M. R. (2022). Antibiotic resistance, phylogenetic typing, and virulence genes profile analysis of uropathogenic Escherichia coli isolated from patients in southern Iraq,” J. Appl. Genet., 63(2) 401–412.

Alansary I M. M., Nadal A. (2022). Detection of Biofilm Formation in Classical and Hypervirulent Klebsiella pneumoniae.Al-Mustansiriyah J. Sci., 33(5) 65-71

Collee, J. G., Fraser, A. G., Marmino, B. P., & Simons, A. (1996). Mackin and McCartney Practical Medical Microbiology. The Churchill Livingstone, Inc. U.S.A. 14(55)

Naji S.A, Halah A. A. (2023). A Study of Urinary Tract Infections Prevalence, Antibiotics Resistance, and Biofilm Formation Capability of the Bacterial Causal Agents. Tikrit Journal of Pure Sci., 27(6) 11-17.

Shah MA, Kassab YW, Anwar MF, Al Dahoul HK, Menon S, Kaur HJ. (2019). Prevalence and associated factors of urinary tract infections among diabetic patients. Health Sci J. 13(1) 1–5.

Willy N., Joseph W G., Nancy W. M. (2020). Prevalence of Urinary Tract Infection, Microbial Aetiology, and Antibiotic Sensitivity Pattern among Antenatal Women Presenting with Lower Abdominal Pains at Kenyatta National Hospital, Nairobi, Kenya. Journal of Science and Technology 3(3): 1-9.

Kerure S B., Rajeshwari S., Sheela S. (2013). Asymptomatic bacteriuria among pregnant women. International Journal of Reproduction Contraception Obstetrics and Gynecology, 2(2) 213

Mahdi BM, Khudhur HB, Abdul-Hussein MM. (2020). Bacterial isolates of urine and their susceptibility to antimicrobials. Macedonian J Med Sci. 8(A) 84-88.

Armanullah M, Anjay, Kumar P, Kumari S, Kaushik P, Archana S, Das Arya K. (2018). Prevalence of multi-drug resistant (MDR) Escherichia coli in bovine clinical samples. Int J Curr Microbiol App Sci. 7(1) 1476-1485.

Yaratha, G., Perloff, S., and Changala, K. (2017). Lactose vs. non-lactose fermenting E. coli: epidemiology, clinical outcomes, and resistance. In Open forum infectious diseases 4(1) 589-590.

Gajdács, M., Ábrók, M., Lázár, A., and Burián, K. (2020). Differential epidemiology and antibiotic resistance of lactose-fermenting and non-fermenting Escherichia coli: Is it just a matter of taste?. Biologia Futura, 71(1) 175-182.

Etefia E (2023) Virulence Factors of Uropathogenic Escherichia coli. Escherichia coli - Old and New Insights. IntechOpen. Available at: http://dx.doi.org/10.5772/intechopen.99891.

Naji S. A., Halah A. (2022). A Study of Urinary Tract Infections Prevalence, Antibiotics Resistance, and Biofilm Formation Capability of the Bacterial Causal Agents. Tikrit Journal of Pure Sci., 27(6) 11-17.

[23] Knobloch, J. K.; Horsetkotte, M. A.; Rohde, H. and Mack, D. (2020). Evaluation of different detection methods of biofilm formation in Staphylococcus aureus. Med Microbial Immunol, 191(2),101-6.

Head, K. A. (2018). Natural approaches to prevention and treatment of the lower urinary tract. Alternative Medicine Rev., 13(3) 227-244

Pollack, R.A; Findlay, L; Mondschein, W and Modesto, R. (2012). Laboratory Exercises in Microbiology , John Wiley & Sons, Inc, printed in the USA ,4: 273.

Cockerill, F.R., Wikler, M.A., Alder, F.J., Dudley, M.N., Eliopoulos, G.M., Ferraro, M.J., Hardy, M.D.J., Hecht, D.W., Hindler, J.A., Patel, J.B., Mair Powell, F., Swenson, Frcp. J.M., Jr., R.B.T., Traczewski, M.M., Turnidge, J.D., Weinstein, M.P., Zimmer, B.L.(2012). Performance Standards for Antimicrobial Susceptibility Testing ; Twenty-Second Informational Supplement.

Sorlozano A, Gutierrez J, Romero, J .M, Luna, J. (2017). Activity in vitro of twelve antibiotic against clinical isolates of extended – spectrum beta = lactamase producing Escherichia .coli . Journal of Basic Microbiology, 47, 413-416.

Abdul-Lateef, M.S. and Abdul-Razzaq, L.A. (2011) . Molecular phylogeny of Escherichia coli isolated from clinical samples in Hilla, Iraq. Afr J Biotechnol.10(70): 15783-15787.

Al-Hadithi H. A. A. (2018). Molecular detection of Hemolycin in Escherichia coli and attempt to inhibition by using the Probiotics. Tikrit J. Pur Sci., 23(6) 79-90

Khan N, Noor us S, Abdus S, Qazilbash A. (2012). Incidence and AntibiogramPatterns of Escherichia coli Isolated from Various Clinical Samplesfrom Patients at N.I.H. Islamabad. Pakistan Journal of Biological Sci-ences. 5.

Adinortey C, Amewowor DHAK, Otwe E, Galyuon I, Asante DKA. (2017). Antibiotic Susceptibility Profile and Occurrence of Escherichiacoli Isolated from Clinical and Environmental Samples in CapeCoast, Ghana. Research Journal of Microbiology. 12(1) 170–6.

AL-Jubouri S. S. and Abdul-Muhsin M. S. (2022). Molecular Detection of Cephalosporin Resistance Genes in Escherichia coli Isolated from Urinary Tract Infections in Baghdad Hospitals. Iraqi Journal of Biotechnology, 21(2): 145-152.

Manandhar S., Singh A., Varma A., Pandey S., Shrivastava N. (2018). Biofilm producing clinical Staphylococcus aureus isolates augmented prevalence of antibiotic resistant cases in tertiary care hospitals of Nepal. Frontiers in Microbiology. 9: 2749.

Downloads

Published

2026-07-12

Issue

Section

Original Article

Categories

How to Cite

1.
Hussien SS, Noraldeen MY, Raoof AA. Investigation of biofilm production and antibiotic susceptibility in Escherichia coli isolated from urinary tract infections. NTU-JPS [Internet]. 2026 Jul. 12 [cited 2026 Nov. 6];5(2):1-9. Available from: https://ntu.libraryhost.com/index.php/NTU-JPS/article/view/1001

Similar Articles

1-10 of 26

You may also start an advanced similarity search for this article.